Concepedia

De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trial

Daniel Ma, Katharine A. Price, Eric J. Moore, Samir H. Patel, Michael L. Hinni, David M. Routman, Briant Fruth, Nathan R. Foster, Kathryn M. Van Abel, Linda X. Yin,

The Lancet Oncology · 2025 · 19 citations · 21 references

DOI

Concepts

References

21

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Anil K. Chaturvedi, Eric A. Engels, Ruth M. Pfeiffer et al. · Journal of Clinical Oncology · 2011 · 3.6K citations · Full text

, , +11

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison, Andy Trotti, Jonathan Harris et al. · The Lancet · 2018 · 1.3K citations

, , +6

Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma

G. Calais, M. Alfonsi, É. Bardet et al. · JNCI Journal of the National Cancer Institute · 1999 · 1.1K citations

, , +9

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Hisham Mehanna, Max Robinson, A. Hartley et al. · The Lancet · 2018 · 1K citations · Full text

, , +12

US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines

Mona Saraiya, Elizabeth R. Unger, Trevor Thompson et al. · JNCI Journal of the National Cancer Institute · 2015 · 762 citations · Full text

, , +17